Paola Biason

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona et al. · Journal of Clinical Oncology · 2006 · 333 citations · Full text

Predictive Role of the <i>UGT1A1</i>, <i>UGT1A7</i>, and <i>UGT1A9</i> Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

Erika Cecchin, Federico Innocenti, Mario D’Andrea et al. · Journal of Clinical Oncology · 2009 · 215 citations · Full text

Genetics, Genetic Epidemiology, Pathology +16

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases

Fotios Loupakis, Shruti Sharma, Madiha Derouazi et al. · JCO Precision Oncology · 2021 · 127 citations · Full text

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 107 citations · Full text

Class 1, 2, and 3 <i>BRAF</i> -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization

Marta Schirripa, Paola Biason, Sara Lonardi et al. · Clinical Cancer Research · 2019 · 104 citations · Full text